Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 309

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood

Open access
Higgins, Michaela J., Jelovac, Danijela, Barnathan, Evan, Blair, Brian, Slater, Shannon, Powers, Penny, Zorzi, Jane, Jeter, Stacie C., Oliver, George R., Fetting, John, Emens, Leisha, Riley, Carol, Stearns, Vered, Diehl, Frank, Angenendt, Philipp, Huang, Peng, Cope, Leslie, Argani, Pedram, Murphy, Kathleen M., Bachman, Kurtis E., Greshock, Joel, Wolff, Antonio C., Park, Ben H. · 2012 · Clinical Cancer Research

Abstract

Purpose: We sought to evaluate the feasibility of detecting PIK3CA mutations in circulating tumor DNA (ctDNA) from plasma of patients with metastatic breast cancer using a novel technique called BEAMing. Experimental Design: In a retrospective analysis, 49 tumor and temporally matched plasma samples from patients with breast cancer were screened for PIK3CA mutations by BEAMing. We then prospectively screened the ctDNA of 60 patients with metastatic breast cancer for PIK3CA mutations by BEAMing and compared the findings with results obtained by screening corresponding archival tumor tissue DNA using both sequencing and BEAMing. Results: The overall frequency of PIK3CA mutations by BEAMing was similar in both patient cohorts (29% and 28.3%, respectively). In the retrospective cohort, the concordance of PIK3CA mutation status by BEAMing between formalin-fixed, paraffin-embedded (FFPE) samples and ctDNA from temporally matched plasma was 100% (34 of 34). In the prospective cohort, the concordance rate among 51 evaluable cases was 72.5% between BEAMing of ctDNA and sequencing of archival tumor tissue DNA. When the same archival tissue DNA was screened by both sequencing and BEAMing for PIK3CA mutations (n = 41 tissue samples), there was 100% concordance in the obtained results. Conclusions: Analysis of plasma-derived ctDNA for the detection of PIK3CA mutations in patients with metastatic breast cancer is feasible. Our results suggest that PIK3CA mutational status can change upon disease recurrence, emphasizing the importance of reassessing PIK3CA status on contemporary (not archival) biospecimens. These results have implications for the development of predictive biomarkers of response to targeted therapies. Clin Cancer Res; 18(12); 3462–9. ©2012 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-11-2696

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 39 references

Cited by

See all 309

Metadata

Authors
Higgins, M. J., Jelovac, D., Barnathan, E., Blair, B., Slater, S., Powers, P., Zorzi, J., Jeter, S. C., Oliver, G. R., Fetting, J., Emens, L., Riley, C., Stearns, V., Diehl, F., Angenendt, P., Huang, P., Cope, L., Argani, P., Murphy, K. M., Bachman, K. E., Greshock, J., Wolff, A. C., & Park, B. H.
Venue
Clinical Cancer Research
Published
2012-06-14
Volume
18
Issue
12
Pages
3462-3469
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2128196636
Cited by
309
References
39
FWCI
8.77
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-11-2696
The paper
Higgins, M. J., Jelovac, D., Barnathan, E., Blair, B., Slater, S., Powers, P., Zorzi, J., Jeter, S. C., Oliver, G. R., Fetting, J., Emens, L., Riley, C., Stearns, V., Diehl, F., Angenendt, P., Huang, P., Cope, L., Argani, P., Murphy, K. M., . . . Park, B. H. (2012). Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-11-2696

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.